Status:
COMPLETED
The COVID-19 Pandemic and Exercise Study
Lead Sponsor:
University of British Columbia
Conditions:
Depressive Symptomatology
Psychological Distress
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The COPE Trial is a randomized controlled trial that will provide currently isolated yet generally physically healthy 18-64 year old adults who are pre-retirement with the opportunity to receive a fre...
Detailed Description
Global stay-at-home mandates implemented in response to the COVID-19 pandemic are having substantial negative effects on mental health. Developing approaches to maintain the mental health of all indiv...
Eligibility Criteria
Inclusion
- Between 18-64
- Still working or pre-retirement
- Currently completing less than 150 minutes of moderate activity per week, and/or 75 minutes if vigorous activity per week
- has at-home internet/computer access
- English speaking
Exclusion
- Retired
- Meeting activity guidelines (i.e. at least 150 min of moderate or 75 min of vigorous intensity exercise per week
- Major health conditions that limit ability to exercise
- Hospitalization in the last 3 months
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2020
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT04400279
Start Date
June 1 2020
End Date
November 28 2020
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia
Vancouver, British Columbia, Canada, V6T1Z4